|  | Study period | |||||
---|---|---|---|---|---|---|---|
 | Enrolment | Allocation | Post-allocation | Close-out | |||
Timepoint |  − t1 | 0 | t0: five times a week, for 8 weeks | t1: Once a week during 8 weeks of treatments | t2: 4th week of treatment | t3: 8th week of treatment | T4: 8 weeks after the end of treatment |
Enrolment: | Â | Â | Â | Â | Â | Â | Â |
Eligibility screen | X | Â | Â | Â | Â | Â | Â |
Informed consent | X | Â | Â | Â | Â | Â | Â |
Allocation | Â | X | Â | Â | Â | Â | Â |
Interventions: | Â | Â | Â | Â | Â | Â | Â |
rFMS and sham stimulation | Â | Â | X | Â | Â | Â | Â |
Medication | Â | Â | X | Â | Â | Â | Â |
Bladder management strategy | Â | X | Â | Â | Â | Â | Â |
Acupuncture treatment | Â | Â | X | Â | Â | Â | Â |
Assessments: | Â | Â | Â | Â | Â | Â | Â |
Bladder capacity | X | Â | Â | Â | Â | X | X |
Pdet | X | Â | Â | Â | Â | X | X |
Bladder compliance | X | Â | Â | Â | Â | X | X |
Residual volume of the bladder | X | Â | Â | X | Â | Â | X |
Bladder diary | X | Â | Â | X | Â | Â | X |
SCI-QOL | X | Â | Â | Â | X | X | X |
NBSS | X | Â | Â | Â | X | X | X |
Pudendal nerve electromyography | X | Â | Â | Â | Â | X | X |